Research Article
The Leading Concerns of American Women with Nausea and Vomiting of Pregnancy Calling Motherisk NVP Helpline
Table 4
Breakdown of the 68 women calling for NVP management info/and safety information on drugs used for controlling nausea or vomiting.
| Reason for initial call | | % | GA (GW ± St. Dev.) | GA range (GW) |
| NVP info and Unisom + vit B6 | 26 | 13.33 | 11.98 ± 2.89 | 4–21 | NVP info and Zofran | 16 | 8.21 | 11.77 ± 6.25 | 2–22 | NVP info and Unisom + vit B6, and acid | 9 | 4.62 | 7.61 ± 1.02 | 7–10 | NVP info and Unisom | 4 | 2.05 | 8.17 ± 0.58 | 7.5–8.5 | NVP info and vit B6 | 3 | 1.54 | 8.5 ± 1.41 | 7.5–9.5 | NVP info and Diclectin | 3 | 1.54 | 7.33 ± 0.76 | 6.5–8 | NVP info and nonmedical advice | 2 | 1.03 | 7 | | NVP info and Zofran and Unisom + vit B6 and acid | 2 | 1.03 | 6 | | NVP info and Zofran and Unisom + vit B6 | 1 | 0.51 | 11 | | NVP info and Zofran and vit B6, and acid | 1 | 0.51 | — | | NVP info, dimenhydrinate, meclizine, and acid | 1 | 0.51 | 8 | |
| Total | 68 | 35% | | |
|
|
GW: Gestational weeks.
|